OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin: a dose‐finding study

HTML

Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12038
Authors: J. P. H. Wilding, E. Ferrannini, V. A. Fonseca, W. Wilpshaar, P. Dhanjal, A. Houzer
Institutions: University of Liverpool, Aintree University Hospital, University of Pisa, Tulane University, Astellas Pharma (Netherlands)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: ipragliflozin, SGLT2 inhibitors, type 2 diabetes, inadequate glycaemic control, metformin monotherapy, dose-finding, HbA1c, glycemic control, weight loss, blood pressure reduction, urinary tract infection, hypoglycemia, drug safety
SDG: Good health and well-being

Open Access status: closed

Funder: Astellas Foundation for Research on Metabolic Disorders
OpenAlex ID: W2137467405
FWCI: 9.049
Cites: 26
Cited by: 126
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security